2018 US Drugs of Abuse Testing Analyzers and Reagents: Supplier Sales and Shares, Sales Segment Forecasts--Hospitals, Commercial Laboratories, POC Locations--Competitive Landscape, Emerging Technologies, Instrumentation Review

Publisher Name :
Date: 09-Jul-2018
No. of pages: 278

This new 278-page report from VPGMarketResearch provides a comprehensive analysis of the US drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.

The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxyphene.

During the next five years, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.

This report is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; and provides test volume and sales forecasts, by market segment and individual assay.

Contains 278 pages and 20 tables

2018 US Drugs of Abuse Testing Analyzers and Reagents: Supplier Sales and Shares, Sales Segment Forecasts--Hospitals, Commercial Laboratories, POC Locations--Competitive Landscape, Emerging Technologies, Instrumentation Review

Table of Contents

Introduction
Market and Technology Overview
A. Major Drugs of Abuse
1. Overview
2. Test Methodologies
3. Amphetamines
4. Barbiturates
5. Benzodiazepines
6. Cannabinoids/Marijuana
7. Cocaine
8. Lysergic Acid Diethylamide (LSD)
9. Methadone
10. Methaqualone
11. Opiates
12. Phencyclidine
13. Tricyclic Antidepressants
B. Instrumentation Review
C. Major In Vitr-*Diagnostic Technologies and Their Potential Applications
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
d. Chemiluminescence
c. Enzyme Immunoassays (EIA)
° Overview
° ELISA
° EMIT
° Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
6. Biosensors
U.S.A.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Rationale for Testing Decentralization
1. Overview
2. Regulatory Trends
3. Economic Trends
4. Demographic Trends
5. Technological Trends
6. Social Trends
7. Quality of Care
8. Defensive Medicine
9. Quality Control Issues
E. Market Size, Growth and Major Instrument and Reagent Suppliers' Sales and Market Shares
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Strategies
- Abbott Laboratories
- AdnaGen
- Agilent Technologies
- Beckman Coulter/Danaher
- Biomedical Diagnostics
- BioMerieux
- Bio-Rad
- DiaSorin
- Eiken
- Fujirebio/Innogenetics
- Grifols
- Instrumentation Laboratory
- Kyowa Medex
- Matritech/Alere
- Ortho-Clinical Diagnostics
- Quest Diagnostics
- Roche
- Siemens
- Sysmex
- Therm-*Fisher
- Tosoh
- Wako
- Wallac/PE

List of Tables

Major Companies Developing or Marketing Drugs of Abuse Tests
U.S.A., Drugs of Abuse Test Volume Forecast by Market Segment
U.S.A., All Market Segments, Drugs of Abuse Test Volume Forecast by Assay
U.S.A., Hospital Laboratories, Drugs of Abuse Test Volume Forecast by Assay
U.S.A., Commercial/Private Laboratories, Drugs of Abuse Test Volume Forecast By Assay
U.S.A., Physician Offices/Group Practices, Drugs of Abuse Test Volume Forecast By Assay
U.S.A., Drugs of Abuse Reagent Market Forecast by Market Segment by Assay
U.S.A., All Market Segments, Drugs of Abuse Reagent Market Forecast by Assay
U.S.A., Hospital Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
U.S.A., Commercial/Private Laboratories, Drugs of Abuse Reagent Market Forecast By Assay
U.S.A., Physician Offices/Group Practices, Drugs of Abuse Reagent Market Forecast By Assay
U.S.A., Ancillary Hospital Locations Estimated Number
U.S.A., Ancillary Hospital Locations Annual Utilization
U.S.A., Hospital Emergency Departments Drugs of Abuse Test Volume Forecast
U.S.A., Hospital Emergency Departments Drugs of Abuse Reagent and Instrument Sales Forecast
U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
U.S.A., Ambulatory Care Centers Drugs of Abuse Test Volume Forecast
U.S.A., Ambulatory Care Centers Drugs of Abuse Reagent and Instrument Sales Forecast
U.S.A., Major Suppliers of Immunodiagnostic Products, Estimated Market Shares
  • Global Teicoplanin Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 14-Nov-2018        Price: US 3480 Onwards        Pages: 121
    Teicoplanin is an antibiotic used in the prophylaxis and treatment of serious infections caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus and Enterococcus faecalis. It is a semisynthetic glycopeptide antibiotic with a spectrum of activity similar to vancomycin. Its mechanism of action is to inhibit bacterial cell wall synthesis. Scope of the Report: This report focuses on the Teicoplanin in global market, especially in North Am......
  • Hemophilia A - Pipeline Review, H2 2018
    Published: 13-Nov-2018        Price: US 2000 Onwards        Pages: 186
    Hemophilia A - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hemophilia A - Pipeline Review, H2 2018, provides an overview of the Hemophilia A (Hematological Disorders) pipeline landscape. Hemophilia A is an X-linked, recessive disorder caused by deficiency of functional plasma clotting factor VIII (FVIII), which may be inherited or arise from spontaneous mutation. Depending on the level......
  • Global Human Immunoglobulin Market Insights, Forecast to 2025
    Published: 13-Nov-2018        Price: US 3900 Onwards        Pages: 95
    This report studies the global market size of Human Immunoglobulin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Human Immunoglobulin in these regions. This research report categorizes the global Human Immunoglobulin market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, marke......
  • Aplastic Anemia - Pipeline Review, H2 2018
    Published: 13-Nov-2018        Price: US 2000 Onwards        Pages: 80
    Aplastic Anemia - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Aplastic Anemia - Pipeline Review, H2 2018, provides an overview of the Aplastic Anemia (Hematological Disorders) pipeline landscape. Aplastic anemia is a syndrome of bone marrow failure characterized by peripheral pancytopenia and marrow hypoplasia. Symptoms include fatigue, pale skin, rapid or irregular heart rate, shortne......
  • Hypereosinophilic Syndrome - Pipeline Review, H2 2018
    Published: 13-Nov-2018        Price: US 2000 Onwards        Pages: 69
    Hypereosinophilic Syndrome - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypereosinophilic Syndrome - Pipeline Review, H2 2018, provides an overview of the Hypereosinophilic Syndrome (Hematological Disorders) pipeline landscape. "The hypereosinophilic syndrome (HES) is a disease characterized by a persistently elevated eosinophil count (? 1500 eosinophils/mm³) in the blood for at least......
  • Fanconi Anemia - Pipeline Review, H2 2018
    Published: 13-Nov-2018        Price: US 2000 Onwards        Pages: 53
    Fanconi Anemia - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fanconi Anemia - Pipeline Review, H2 2018, provides an overview of the Fanconi Anemia (Hematological Disorders) pipeline landscape. Fanconi anemia (fan-KO-nee uh-NEE-me-uh), or FA, is a rare, inherited blood disorder that leads to bone marrow failure. The disorder also is called Fanconi's anemia. FA is a type of aplastic anem......
  • Global Thalidomide Market Insights, Forecast to 2025
    Published: 13-Nov-2018        Price: US 3900 Onwards        Pages: 111
    This report studies the global market size of Thalidomide in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Thalidomide in these regions. This research report categorizes the global Thalidomide market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities an......
  • Global Axitinib Market Insights, Forecast to 2025
    Published: 13-Nov-2018        Price: US 3900 Onwards        Pages: 111
    This report studies the global market size of Axitinib in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Axitinib in these regions. This research report categorizes the global Axitinib market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challen......
  • Global Combination Therapy Drug Market Insights, Forecast to 2025
    Published: 13-Nov-2018        Price: US 3900 Onwards        Pages: 110
    This report studies the global market size of Combination Therapy Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Combination Therapy Drug in these regions. This research report categorizes the global Combination Therapy Drug market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future t......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs